Cold Application on the Subcutaneous Injection

Inclusion Criteria: * to receive LMWH (pre-filled syringe containing 40 mg enoxaparin sodium in 0.4 ml) treatment at least once a day * not to have any visual or auditory disorders * not to have any foreknown coagulation disorders * to have platelet, PTT and international normalized ratio (INR) values within the normal limits for beginning enoxaparin sodium injections * not to have any hematologic disorders or any bruising or injuries at the abdominal wall * to receive no injections at the abdominal site, other than the enoxaparin sodium during the research protocol * to will to participate in this study Exclusion Criteria: * to be pregnant * have bleeding in the injection site * have pain at any site of their body prior to the injection * have any incision, drain, scar tissue, lipodystrophy or infection symptoms at the abdominal site which hinder the application of injection * not to will to participate in this study